SCHEMBL4445301

SCHEMBL4445301

O=C(O)OCC=CCl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11039888 0.83 ALDH1A1 (0.35)
SCHEMBL11896861 0.83 ALDH1A1 (0.35)
SCHEMBL408600 0.79
SCHEMBL14964626 0.78 ALDH1A1 (0.32)
SCHEMBL308302 0.77
SCHEMBL10351921 0.77
SCHEMBL400163 0.77
SCHEMBL608342 0.77
SCHEMBL643456 0.76
SCHEMBL10912039 0.75

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 80 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6602976-B2 Barrery electrolyte LITHDYNE INTERNATIONAL 2003-08-05 US claimed
US-20020168575-A1 Polycarbonate oligomers and polymers for use in electrolytes SMITH W NOVIS (US) 2002-11-14 US claimed
EP-0393936-A1 3-substituted-2-oxindole derivatives as antiinflammatory agents PFIZER INC. (US) 1990-10-24 EP claimed
US-20240207411-A1 LYMPHATIC SYSTEM-DIRECTING LIPID PRODRUGS SEAPORT THERAPEUTICS, INC. 2024-06-27 US disclosed
CN-118063537-A Prodrugs of directed lymphatics 莫纳什大学 2024-05-24 CN disclosed
US-11975073-B2 Lipid prodrugs of neurosteroids PURETECH LYT, INC. (US) 2024-05-07 US disclosed
US-20240139327-A1 PRODRUG COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF MINGHUI PHARMACEUTICAL (HANGZHOU) LIMITED (CN) 2024-05-02 US disclosed
US-11938137-B2 Lipid prodrugs of mycophenolic acid and uses thereof PURETECH LYT, INC. (US) 2024-03-26 US disclosed
CN-108137482-B Prodrugs of directed lymphatics 莫纳什大学 2024-03-15 CN disclosed
US-20240050573-A1 LYMPH DIRECTING PRODRUGS MONASH UNIVERSITY (AU) 2024-02-15 US disclosed
US-11883497-B2 Lymphatic system-directing lipid prodrugs PURETECH LYT, INC. (US) 2024-01-30 US disclosed
US-6602976-B2 Barrery electrolyte LITHDYNE INTERNATIONAL 2003-08-05 US disclosed
US-20020168575-A1 Polycarbonate oligomers and polymers for use in electrolytes SMITH W NOVIS (US) 2002-11-14 US disclosed
EP-1024406-A1 Resist composition WAKO PURE CHEMICAL INDUSTRIES LTD (JP) 2000-08-02 EP disclosed
US-5120841-A Antibiotics for easy absorption TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1992-06-09 US disclosed
EP-0128029-B1 CEPHALOSPORIN ESTER DERIVATIVES, THEIR PRODUCTION AND USE Takeda Chemical Industries, Ltd. (JP) 1989-02-08 EP disclosed
US-4729992-A Cephalosporin esters, their production and use TATSUO CHEMICAL IND., LTD. (JP) 1988-03-08 US disclosed
EP-0159899-A2 Cephalosporin esters, their production and use Takeda Chemical Industries, Ltd. (JP) 1985-10-30 EP disclosed
EP-0128029-A2 Cephalosporin ester derivatives, their production and use Takeda Chemical Industries, Ltd. (JP) 1984-12-12 EP disclosed
US-4120888-A REACTING PHOSGENE WITH AN EPOXY MINEREC CORPORATION (US) 1978-10-17 US disclosed